The Scientist - Home

Nature recently announced that they will publish peer review reports with papers. Editors and researchers weigh the impact.

Genetically modified pigs have led to a breakthrough in xenotransplantation, but it didn’t eliminate all possibilities of organ rejection.

A study of more than 24,000 people in Taiwan showed that those who endured frequent and intense heat waves over 15 years appeared older than their actual age.

Microbeads made from green tea and seaweed-derived compounds may offer a safer, less invasive way to lose weight than current options.

Identifying the mutations that underly unusual sleep traits can provide insights into the biology of sleep and circadian function in humans.

A vaccine successfully induced specific B cells in rhesus macaques, paving the way for an effective HIV vaccine in humans.

Severe cuts to science research funding put graduate students at risk of not finishing their degrees. The American Chemical Society launched a grant to support students in crisis. 

Thought too hard to do, a new platform evolved proteins in mammalian cells, which could help researchers design drugs that work better in humans. 

With complicated lifecycles and genetics, parasitic worms can be hard to study, but organoids unveil new insight into their biology and a path to better drugs.

Gut bacteria bioaccumulated so-called forever chemicals, leading to new insights on how PFAS affects biology and paths to bioremediation.

The academic system prioritizes publications and grants over real-world impact; researchers now advocate for a shift to value collaboration and translational discoveries.

Triple-negative breast cancer cells build bridges to activate adipocytes and fuel themselves, highlighting a target for future therapies.